Hyaluron+collagen-Watsons Health


Amikacin sulfate is a medicine that is an aminoglycoside antibiotic. It is active against a wide range of microorganisms such as Gram-negative bacteria. It acts to inhibit protein synthesis in bacteria by binding to the 50s ribosomal subunit. This medicine is available as an injection.

Amikacin sulfate is used in the following conditions:

  • Severe Gram -negative bacterial infections
  • Uncomplicated UTI

Do not give Amikacin sulfate to people with the following conditions:

  • Hypersensitivity to amikacin and other aminoglycosides
  • Myasthenia gravis

Amikacin sulfate may have the following side effects:

  • Neurotoxicity manifested as vestibular and permanent bilateral auditory ototoxicity
  • Skin rash
  • Drug fever
  • Headache
  • Paresthesia
  • Nausea and vomiting
  • Eosinophilia
  • Arthralgia
  • Anaemia
  • Nephrotoxicity
  • Neuromuscular blockade and respiratoryparalysis
  • Clostridium difficile-associated colitis


Take extra caution in patients with the following medical conditions:

  • Patient with pre-existing hearing or vestibular damage
  • Muscular disorder such as parkinsonism
  • Renal impairment
  • Premature and neonatal infants
  • Pregnancy
  • Lactation



Amikacin sulfate may interact with the following medicines:

Symptoms of overdosage include the following:

  • Nephrotoxicity
  • Ototoxicity
  • Neuromuscular blockade and respiratoryarrest

Seek medical help immediately.


Available Brands:

Amicare, Amicyn, Amikacide, Cinmik, Kormakin, Phil Pharmawealth, Kamin, Mican, Mikalogis, Mikasul, Nica, Panmikin



Related Articles

Vaccine, DTP

DTP vaccine (Diphtheria and Tetanus toxoids and Pertussis adsorbed vaccine) is a combination vaccine used to induce specific antibody production, thus promoting immunity [...]


Teicoplanin is a glycopeptide antibiotic drug that inhibits the growth of susceptible organisms by disrupting cell-wall synthesis. It binds to D-alanyl-D-alanine residues resulting to peptidoglycan synthesis blockage. Use this [...]


Secukinumab is a human monoclonal antibody, Immunoglobulin G1/K that binds selectively to interleukin-17A (IL-17A), a natural cytokine affecting normal inflammatory and immune responses. It inhibits the release [...]